Adolfo Capó

Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

Ronald B. Natale, David Bodkin, Ramaswamy Govindan et al. · Journal of Clinical Oncology · 2009 · 226 citations · Full text

Medicine, Oncology, Pharmacology +17

ZD6474 versus gefitinib in patients with advanced NSCLC: Final results from a two-part, double-blind, randomized phase II trial

Ronald B. Natale, David Bodkin, Ramaswamy Govindan et al. · Journal of Clinical Oncology · 2006 · 109 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa™) in patients with NSCLC: Results of a randomized, double-blind Phase II study

R. Natale, David Bodkin, Ramaswamy Govindan et al. · Lung Cancer · 2005 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +6

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

Henry Gómez, Silvia P. Neciosup, C. Tosello et al. · Clinical Breast Cancer · 2015 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16